Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.92 -0.20 (-6.41%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.92 unch (unch) 17:27 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.90
Day High
3.11
Open 3.10
Previous Close 3.12 3.12
Volume 555,600 555,600
Avg Vol 948,805 948,805
Stochastic %K 5.59% 5.59%
Weighted Alpha -64.05 -64.05
5-Day Change -0.43 (-12.84%) -0.43 (-12.84%)
52-Week Range 2.89 - 11.40 2.89 - 11.40
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 254,910
  • Shares Outstanding, K 87,298
  • Annual Sales, $ 0 K
  • Annual Income, $ -88,850 K
  • EBIT $ -102 M
  • EBITDA $ -101 M
  • 60-Month Beta -0.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.77

Options Overview Details

View History
  • Implied Volatility 90.18% ( -0.05%)
  • Historical Volatility 64.57%
  • IV Percentile 30%
  • IV Rank 15.62%
  • IV High 431.76% on 03/20/25
  • IV Low 26.95% on 10/08/24
  • Put/Call Vol Ratio 1.07
  • Today's Volume 29
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 7,760
  • Open Int (30-Day) 7,998

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 4
  • High Estimate -0.26
  • Low Estimate -0.30
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +3.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.89 +0.86%
on 03/28/25
Period Open: 3.69
3.77 -22.55%
on 03/03/25
-0.77 (-20.87%)
since 02/28/25
3-Month
2.89 +0.86%
on 03/28/25
Period Open: 5.77
5.95 -50.92%
on 01/06/25
-2.85 (-49.39%)
since 12/27/24
52-Week
2.89 +0.86%
on 03/28/25
Period Open: 6.56
11.40 -74.39%
on 09/10/24
-3.64 (-55.49%)
since 03/28/24

Most Recent Stories

More News
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

TERN : 2.92 (-6.41%)
This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Last year, Viking Therapeutics, a mid-cap biotech, made waves after it reported excellent phase 2 results for an investigational medicine for weight loss, the industry's hottest and perhaps fastest-growing...

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

TERN : 2.92 (-6.41%)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

TERN : 2.92 (-6.41%)

Business Summary

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY,...

See More

Key Turning Points

3rd Resistance Point 3.27
2nd Resistance Point 3.19
1st Resistance Point 3.06
Last Price 2.92
1st Support Level 2.84
2nd Support Level 2.76
3rd Support Level 2.63

See More

52-Week High 11.40
Fibonacci 61.8% 8.15
Fibonacci 50% 7.15
Fibonacci 38.2% 6.14
Last Price 2.92
52-Week Low 2.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies